End-of-day quote
Colombo S.E.
23:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
75
LKR
|
0.00%
|
|
+1.08%
|
+16.64%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,565
|
3,773
|
4,754
|
27,633
|
14,916
|
16,728
|
Enterprise Value (EV)
1 |
6,234
|
8,189
|
8,001
|
30,835
|
23,975
|
19,690
|
P/E ratio
|
5.3
x
|
3.95
x
|
3.05
x
|
9.07
x
|
4.54
x
|
2.87
x
|
Yield
|
5%
|
6.3%
|
9.38%
|
4.52%
|
5.38%
|
11.1%
|
Capitalization / Revenue
|
0.23
x
|
0.18
x
|
0.21
x
|
1.08
x
|
0.45
x
|
0.27
x
|
EV / Revenue
|
0.4
x
|
0.39
x
|
0.35
x
|
1.21
x
|
0.72
x
|
0.32
x
|
EV / EBITDA
|
4.11
x
|
4.07
x
|
2.66
x
|
6.2
x
|
6.51
x
|
2.16
x
|
EV / FCF
|
-15.3
x
|
-5.54
x
|
6.17
x
|
615
x
|
-2.52
x
|
3.06
x
|
FCF Yield
|
-6.53%
|
-18.1%
|
16.2%
|
0.16%
|
-39.7%
|
32.6%
|
Price to Book
|
0.48
x
|
0.46
x
|
0.51
x
|
2.06
x
|
0.82
x
|
0.76
x
|
Nbr of stocks (in thousands)
|
297,124
|
297,124
|
297,124
|
297,124
|
297,124
|
297,124
|
Reference price
2 |
12.00
|
12.70
|
16.00
|
93.00
|
50.20
|
56.30
|
Announcement Date
|
01/06/18
|
03/06/19
|
03/07/20
|
02/06/21
|
03/06/22
|
06/06/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
15,518
|
20,918
|
22,823
|
25,485
|
33,160
|
60,943
|
EBITDA
1 |
1,517
|
2,012
|
3,009
|
4,976
|
3,684
|
9,109
|
EBIT
1 |
1,090
|
1,533
|
2,494
|
4,416
|
3,079
|
8,274
|
Operating Margin
|
7.03%
|
7.33%
|
10.93%
|
17.33%
|
9.29%
|
13.58%
|
Earnings before Tax (EBT)
1 |
926.4
|
1,353
|
2,176
|
4,490
|
4,656
|
8,258
|
Net income
1 |
672.4
|
955.4
|
1,559
|
3,047
|
3,288
|
5,823
|
Net margin
|
4.33%
|
4.57%
|
6.83%
|
11.96%
|
9.91%
|
9.56%
|
EPS
2 |
2.263
|
3.216
|
5.246
|
10.25
|
11.06
|
19.60
|
Free Cash Flow
1 |
-406.8
|
-1,479
|
1,298
|
50.17
|
-9,526
|
6,427
|
FCF margin
|
-2.62%
|
-7.07%
|
5.69%
|
0.2%
|
-28.73%
|
10.55%
|
FCF Conversion (EBITDA)
|
-
|
-
|
43.13%
|
1.01%
|
-
|
70.56%
|
FCF Conversion (Net income)
|
-
|
-
|
83.26%
|
1.65%
|
-
|
110.36%
|
Dividend per Share
2 |
0.6000
|
0.8000
|
1.500
|
4.200
|
2.700
|
6.250
|
Announcement Date
|
01/06/18
|
03/06/19
|
03/07/20
|
02/06/21
|
03/06/22
|
06/06/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,668
|
4,416
|
3,247
|
3,202
|
9,060
|
2,962
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.759
x
|
2.194
x
|
1.079
x
|
0.6435
x
|
2.459
x
|
0.3252
x
|
Free Cash Flow
1 |
-407
|
-1,479
|
1,298
|
50.2
|
-9,526
|
6,427
|
ROE (net income / shareholders' equity)
|
9.76%
|
12.2%
|
17.7%
|
27.6%
|
20.7%
|
28.3%
|
ROA (Net income/ Total Assets)
|
4.62%
|
5.59%
|
8.11%
|
12.3%
|
5.88%
|
12.9%
|
Assets
1 |
14,561
|
17,076
|
19,211
|
24,749
|
55,869
|
45,155
|
Book Value Per Share
2 |
25.00
|
27.80
|
31.40
|
45.10
|
61.20
|
74.50
|
Cash Flow per Share
2 |
3.000
|
2.980
|
3.850
|
7.860
|
10.50
|
17.10
|
Capex
1 |
325
|
390
|
692
|
1,052
|
1,678
|
1,907
|
Capex / Sales
|
2.09%
|
1.86%
|
3.03%
|
4.13%
|
5.06%
|
3.13%
|
Announcement Date
|
01/06/18
|
03/06/19
|
03/07/20
|
02/06/21
|
03/06/22
|
06/06/23
|
|
1st Jan change
|
Capi.
|
---|
| +16.64% | 75.02M | | +2.56% | 102B | | -1.20% | 66.01B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +4.25% | 32.28B | | +8.78% | 19.57B | | +12.32% | 16.77B | | +17.69% | 15.08B | | +8.31% | 14.83B |
Other Commodity Chemicals
|